TECH OUTLOOKMAY - 202119was a delay in moving the records to an approved state within the eTMF. Just in Time GCP helped them optimize the technology to meet their current business needs, perform a risk based retrospective validation and develop the business processes that ensured that they used the system at its full capability. Benefitting from these services, the client maintained a long-term relationship with Just in Time GCP for managing the business side of the system and the ongoing day to day management of the TMF. The true differentiating factors for Just in Time GCP have been the depth of experience, internal process, standards, and commitment to quality it employs while working with clients. The company has collaborative partnerships with several technology vendors, which allows them to help their clients more effectively. Donna remarks, "We have four pillars of leadership defined as collaboration, composure, quality, and balance. We bring these four pillars to the work that we do with our clients." This statement is further strengthened by the fact that Just in Time GCP works not just with its clients but also their partners, technology vendors, and CROs to help bring products that support the patients' needs. Being predominantly a virtual company, Just in Time GCP has continued its work even during the COVID-19 pandemic with over 60 employees spread across the United States. "We adapted to this environment quickly, and we were also able to coach our clients as they adjusted to this new way of working," remarks Donna. Just in Time GCP had to be agile and pull teams together to get the resources and guide the client organizations' newfound resourcing needs. The company has had the opportunity to have supported clients in virtual regulatory inspections, helping their clients shift to a new interaction model with Health Authorities globally. In the post-COVID times, Just in Time GCP is working to create a broader presence as a business and technology consulting company that is supported by a robust services capability. The company continues to expand its consulting services capabilities, in order to better serve the industry during a time of digital transformation, both in terms of business process and technology maturation. We combine our extensive clinical compliance knowledge with a deep understanding of clinical drug development and provide our clients with the best-in-class services
< Page 9 | Page 11 >